Alan Schaffert
Neurology · Modesto, CANPI 1326055880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,996 and has fallen 92.8% since, to $143 in 2022.
Across 178 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$481
- Biogen$322
- Johnson & Johnson$305
- Sunovion Pharmaceuticals Inc.$285
- Novartis$238
- Livanova USA, Inc.$223
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,35597%
- Education$1033%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 23 | $481 |
| Biogen | 20 | $322 |
| Johnson & Johnson | 6 | $305 |
| Sunovion Pharmaceuticals Inc. | 25 | $285 |
| Novartis | 19 | $238 |
| Livanova USA, Inc. | 6 | $223 |
| AbbVie | 17 | $220 |
| Teva Pharmaceuticals USA, Inc. | 4 | $149 |
| AstraZeneca(2 entities) | 3 | $138 |
| Biohaven Pharmaceuticals, Inc. | 9 | $129 |
| Adamas Pharmaceuticals, Inc. | 4 | $124 |
| EMD Serono, Inc. | 2 | $112 |
| Tanabe Pharma America, Inc. | 1 | $100 |
| Acadia Pharmaceuticals Inc | 5 | $71 |
| Kyowa Kirin, Inc. | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 4 | $53 |
| Amneal Pharmaceuticals LLC | 3 | $52 |
| Neurocrine Biosciences, Inc. | 3 | $51 |
| Boston Scientific | 3 | $44 |
| Eisai Inc. | 2 | $37 |
| SK Life Science, Inc. | 2 | $36 |
| Bristol Myers Squibb | 3 | $36 |
| Genentech USA, Inc. | 1 | $24 |
| MDD US Operations, LLC | 1 | $23 |
| Bayer | 1 | $22 |
| Abbott | 1 | $22 |
| Sanofi | 1 | $20 |
| Banner Life Sciences, LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,458 in reported general payments places this provider in the 65th percentile of 1,996 neurology providers in California.
Other neurology in Modesto
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.